Neurocrine Biosciences (NBIX) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $158.29 -0.45%
Revenue Growth %: +26.4%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +26.4%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
